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Abstract. – OBJECTIVE: In this study, we 
aimed to assess the reproducibility and reliabil-
ity of a three-dimensional laser scanner (3DLS) 
in measuring the upper limb volume of BRCL 
women undergoing a 2-week complete decon-
gestive therapy (CDT). 
PATIENTS AND METHODS: 3DLS and CM 
were used to measure the upper limb volume in a 
cohort of BCRL women before (T0) and after (T1) 
a 2-week CDT. We evaluated: a) correlation be-
tween 3DLS and CM at both time points; b) level 
of agreement and the consistency of the different 
measurements at both time points; c) correlation 
between the inter-rater operator analysis in terms 
of total limb volume differences before and after 
rehabilitative treatment of both circumferential 
method and laser scanning 3D in breast cancer 
related lymphedema patients. 
RESULTS: Taken together, 43 BCRL women 
(age 51.1 ± 5.4 years) were included. Both 3DLS 
and CM showed a significant inter and intra-oper-
ator correlation in the arm volume measurement 
at both time-points (T0: r2=0.99, p<0.0001; T1: 
r2=0.99, p<0.0001). 3DLS showed a strong correla-
tion with CM (r2=0.99, p<0.0001) in terms of volume 
measurement and provided greater intra-operator 
correlation (r2=0.92 vs. 0.62) in detecting volume 
variations after the treatment (T1-T0).
CONCLUSIONS: 3DLS confirmed to be high-
ly sensitive, cheap and easy-to-use in the eval-
uation of the upper limb volume in BCRL wom-
en before and after a rehabilitative treatment. 
These findings suggest that augmented reality 
technologies might be very useful in oncologi-
cal rehabilitation.
Key Words:
Lymphedema, Breast cancer, Breast cancer lymph-
edema, Rehabilitation, Upper limb, 3D laser scanner, 
Complete decongestive therapy.
Introduction
Breast cancer (BC) survivorship has been 
continuously increasing for the last years due to 
the improvement in its diagnosis and treatment1-3. 
Given the growing number of BC long-term sur-
vivors, an efficient multidisciplinary approach is 
beneficial in the clinical management of several 
complications that survivors might experience4-7.
Breast cancer related lymphedema (BCRL) 
is a common and detrimental treatment-related 
consequence that involves up to 25% of BC survi-
vors7. This condition can arise up to 11 years after 
surgery8,9. BCRL is characterized by the intersti-
tial accumulation of fluid in the upper extremity 
after surgery and/or radiations, with subsequent 
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negative impact in both health-related quality of 
life (HRQoL) and sanitary costs2,7-12. Early detec-
tion of BCRL is the prerequisite for an optimal 
treatment. 
A key phase in the diagnosis and follow-up 
of BCRL patients is represented by the accurate 
arm volume assessment. For this task, several 
approaches have been proposed over the last few 
years, including water displacement (WD)13-15, 
circumferential method (CM)15-17, and three-di-
mensional laser scanner (3DLS)18-20. WD has been 
traditionally viewed as the “gold standard” proce-
dure to assess the upper limb volume13-15. Regretta-
bly, its use in real-life clinical practice is complex, 
time-consuming, and not recommended in a sub-
stantial proportion of patients, such as those with 
skin lesions21,22. The CM is based on the assump-
tion that the truncated cone solid is a proxy of the 
arm shape, requiring the measurement of specific 
circumferences across the arm to infer its volume23. 
Although several studies questioned the sensitivity 
of CM due to the gibbousness of the upper limbs in 
BCRL patients16,18,22-27, this method is still adopted 
in the clinical practice in many centers. In partic-
ular, this method is troubled by the remarkable de-
gree of heterogeneity in the constellation of locally 
developed measuring protocols23.
Recently, 3DLS-based methods have emerged 
as promising tools for the arm volume measure-
ment18-20. These devices, allowing the real-time 
digital reconstruction of three-dimensional ob-
jects, have been originally implemented in the 
setting of orthopedic conditions, showing great 
performances in terms of accuracy, non-invasive-
ness, and cost-effectiveness28. Accurateness and 
reproducibility of 3DLS and WD have previously 
been compared19, showing that the former is not in-
ferior to the latter for the upper limb volume mea-
surement18,19. Indeed, 3DLS is capable of detecting 
extremely small variations of volume including the 
presence and reduction of gibbousness and swelling 
(e.g., as a consequence of bandages, press therapy, 
manual lymph drainage)29. These characteristics 
might give information on the treatment efficacy 
in order to improve the currently available reha-
bilitation programs18. Recently, our group showed 
that 3DLS might be incorporated into the clinical 
workup of BCRL to allow for a precise, reproduc-
ible, reliable, and cheap diagnosis20. However, up 
to date, to the best of our knowledge, there are no 
studies assessing the reproducibility and reliability 
of 3DLS in quantifying the volume reduction of the 
upper limb after a complete decongestive therapy 
(CDT) in BCRL patients.
In this proof-of-principle study, we sought to 
characterize the reproducibility and reliability 
of a 3DLS compared to CM in upper limb vol-
ume measurement in BCRL women undergoing 
2-week rehabilitation treatment.
Patients and Methods
Participants
We recruited women referred to Outpatient 
Service for the Oncological Rehabilitation of the 
Physical and Rehabilitative Medicine Unity of the 
University Hospital in Novara, Italy from January 
to June 2019. Inclusion criteria were the following: 
a) adult women (aged >18 years); b) BC survivors; 
c) diagnosis of BCRL Stage II-III; d) breast sur-
gery performed by at least 6 months; e) absence 
of skin lesions at upper limb level; f) absence of 
trauma and/or other conditions able to modify 
arm structure and volume. We excluded patients 
with: a) cardiovascular comorbidities; b) vascular 
pathologies involving upper limb; c) anemia ([Hb] 
<9 g/dl); d) severe thrombocytopenia (<100,000 
platelets/mm3); e) history of bleeding; f) central 
nervous system lymphomas; g) metastases of any 
kind and/or concomitant brain tumors; h) being 
unable to sign informed consent. The study was 
approved by the Institutional Review Board. Par-
ticipants were properly informed about the aims 
of the research, testing procedures, personal data 
treatment, and the possibility of withdrawal at 
any time. Written informed consent was obtained 
from each subject before taking part in the ex-
periment and all the procedures were conducted 
according to the principles of the Declaration of 
Helsinki. 
Study Design
All patients underwent a 2-week CDT, con-
sisting of 5 sessions per week for a total of 10 
sessions. Each session included skincare, manu-
al lymphatic drainage, and multi-layer inelastic 
lymphoedema bandaging, and exercise therapy. 
The upper limb volumes of all study participants 
were assessed at the baseline (T0) and at the end 
of the 2-week CDT (T1) by CM and 3DLS. Both 
examinations were performed twice by two phys-
ical therapists with more than 20 years of expe-
rience in lymphedema disorder treatments, for a 
total of four measurements for each subject (mean 
values of the two CM and 3DLS evaluations were 
used for statistical analysis). The study flow chart 
is represented in Figure 1. 
A. de Sire, L. Losco, E. Cigna, L. Lippi, F. Gimigliano, et al
4478
Outcomes
CM
CM consisted of measuring through tape with 
1 mm of sensitivity upper limb circumferences of 
participants. They had to be in an upright sitting 
position with the arm on a table, shoulders in neu-
tral rotation and flexion of 45°, and forearms at 
maximum supination, as described for lymphede-
ma patients30. All the measurements were made in 
correspondence of markers made on the skin from 
wrist to deltoid muscle level, with 5 cm intervals 
(Figure 2a), as previously described in several 
studies16,23. Subsequently, the marker points were 
deleted from the skin surface after each measure-
ment to not influence the operator. 
Figure 1. Study flow chart.
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The arm volume was calculated using the fol-
lowing frustum formula31:
3DLS
A portable 3DLS system, the Structure Sensor 
(Occipital, Inc©, Boulder, CO, USA), was appli-
cated on a common tablet (Figure 2b) and used to 
evaluate the upper limb volumes. All data were 
saved and processed using the software Captevia 
Rodin4D, Version 3.3.3.1 (Rodin SAS©, Merignac, 
France). To guarantee the proper accuracy during 
the scanning phase, it was necessary to ensure 
that subjects could maintain a stable position for 
the entire measurement duration. All 3DLS scans 
were performed with the subject standing and 
with the whole arm fully extended and pronated 
fixed at 90° of shoulder flexion position. In order 
to ensure a proper scanning, 3DLS was placed in 
proximity to the subject at the maximum distance 
of 1 meter in a fixed position on the stand where 
the hand was held up. After scanning, data were 
saved on a laptop and volume was obtained of-
fline through the CAD-CAM Rodin4D, version 
10.0.77.0 (Rodin SAS©, Merignac, France). 
Statistical Analysis
Statistical analysis was performed using the 
GraphPad 6 package, version 6.0 (GraphPad 
Software, Inc©, San Diego, CA, USA). Intra-rat-
er volume measurement differences have been 
evaluated using Wilcoxon test and inter-rater vol-
ume differences by the Mann–Whitney U-test, at 
both time-points. Inter and intra-rater correlation 
were evaluated with Pearson’s correlation (r2) and 
the relationship between volumes measured with 
CM and 3DLS were analyzed using linear regres-
sion, at both time-points. Bland-Altman plot was 
performed to assess the level of agreement and 
the consistency of the two measurements at both 
time-points. Furthermore, the correlation be-
tween the inter-rater operator analysis in terms of 
total limb volume differences after rehabilitative 
treatment of both techniques was assessed using 
linear regression. A type I error (alpha) level of 
0.05 was chosen.
Results
We included 43 BCRL women, mean aged 
51.1 ± 5.4 years, with a mean body mass index 
of 24.2 ± 2.5 kg/m2. Both CM and 3DLS showed 
a high intra-operator reproducibility rate with a 
mean r2=0.99 for both techniques. All results of 
the inter-operator analysis of 3DLS and CM re-
garding every single volume, forearm, arm, and 
total arm showed no differences at any evaluated 
volume (Tables I and II). 
Both 3DLS and CM showed a highly signif-
icant inter-operator correlation in upper limb 
volume measurement (T0: r2=0.99, p<0.0001; 
T1: r2=0.99, p<0.0001) (as showed by Tables I 
and II) regarding every single volume without 
any statistically significant difference between 
the two raters as confirmed by the Mann-Whit-
ney U test. 
3DLS mean volumes showed a strong correla-
tion with CM in total arm volume measurement 
at both time points (T0: r2=0.99, p<0.0001; T1: 
r2=0.99, p<0.0001), as evidenced by Figure 3a. 
A B
Figure 2. A, Marker points on upper limb. B, The three-dimensional laser scanner using a common tablet. 
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 T0 (n=43)
 Intra-operator analysis Inter-operator analysis
 Operator A Operator B Operator A Operator B
 1st measure 2nd measure r2 1st measure 2nd measure r2 Mean Mean r2
  
V1 (dm3) 0.09 ± 0.06 0.09 ± 0.06 0.99 0.09 ± 0.06 0.09 ± 0.06 0.99 0.09 ± 0.06 0.09 ± 0.06 0.99
V2 (dm3) 0.20 ± 0.09 0.20 ± 0.09 0.99 0.20 ± 0.09 0.20 ± 0.09 0.99 0.20 ± 0.09 0.20 ± 0.09 0.99
V3 (dm3) 0.28 ± 0.11  0.28 ± 0.11 0.99 0.28 ± 0.11 0.28 ± 0.11 0.99 0.28 ± 0.11 0.28 ± 0.11 0.99
V4 (dm3) 0.34 ± 0.11 0.34 ± 0.11 0.99 0.34 ± 0.11 0.34 ± 0.11 0.99 0.34 ± 0.11 0.34 ± 0.11 0.99
V5 (dm3) 0.36 ± 0.12 0.36 ± 0.12 0.99 0.36 ± 0.12 0.36 ± 0.12 0.99 0.36 ± 0.12 0.36 ± 0.12 0.99
V6 (dm3) 0.37 ± 0.11 0.37 ± 0.11 0.99 0.37 ± 0.11 0.37 ± 0.11 0.99 0.37 ± 0.11 0.37 ± 0.11 0.99
V7 (dm3) 0.44 ± 0.12 0.44 ± 0.12 0.99 0.44 ± 0.12 0.44 ± 0.12 0.99 0.44 ± 0.12 0.44 ± 0.12 0.99
V8 (dm3) 0.46 ± 0.15 0.46 ± 0.15 0.99 0.46 ± 0.15 0.46 ± 0.15 0.99 0.46 ± 0.15 0.46 ± 0.15 0.99
V forearm (dm3) 1.32 ± 0.44 1.32 ± 0.44 0.99 1.32 ± 0.45 1.32 ± 0.45 0.99 1.32 ± 0.45 1.32 ± 0.45 0.99
V arm (dm3) 1.26 ± 0.37 1.26 ± 0.37 0.99 1.27 ± 0.37 1.27 ± 0.37 0.99 1.27 ± 0.37 1.27 ± 0.37 0.99
V tot (dm3) 2.58 ± 0.79 2.58 ± 0.79 0.99 2.59 ± 0.79 2.59 ± 0.79 0.99 2.59 ± 0.79 2.59 ± 0.79 0.99
 T1 (n=43)
 Intra-operator analysis Inter-operator analysis
 Operator A Operator B Operator A Operator B
 1st measure 2nd measure r2 1st measure 2nd measure r2 Mean Mean r2
  
V1 (dm3) 0.08 ± 0.06 0.08 ± 0.06 0.99 0.08 ± 0.06 0.08 ± 0.06 0.99 0.08 ± 0.06 0.08 ± 0.06 0.99
V2 (dm3) 0.20 ± 0.09 0.20 ± 0.09 0.99 0.20 ± 0.08 0.20 ± 0.09 0.99 0.20 ± 0.09 0.20 ± 0.08 0.99
V3 (dm3) 0.27 ± 0.09 0.27 ± 0.09 0.99 0.27 ± 0.09 0.27 ± 0.09 0.99 0.27 ± 0.09 0.27 ± 0.09 0.99
V4 (dm3) 0.33 ± 0.10 0.33 ± 0.10 0.99 0.34 ± 0.11 0.34 ± 0.10 0.99 0.33 ± 0.10 0.34 ± 0.11 0.99
V5 (dm3) 0.35 ± 0.10 0.35 ± 0.10 0.99 0.35 ± 0.10 0.35 ± 0.10 0.99 0.35 ± 0.10 0.35 ± 0.10 0.99
V6 (dm3) 0.36 ± 0.11 0.35 ± 0.11 0.99 0.36 ± 0.11 0.36 ± 0.11 0.99 0.36 ± 0.11 0.36 ± 0.11 0.99
V7 (dm3) 0.43 ± 0.13 0.43 ± 0.13 0.99 0.43 ± 0.13 0.43 ± 0.13 0.99 0.43 ± 0.13 0.43 ± 0.13 0.99
V8 (dm3) 0.45 ± 0.15 0.45 ± 0.15 0.99 0.45 ± 0.15 0.45 ± 0.15 0.99 0.45 ± 0.15 0.45 ± 0.15 0.99
V forearm (dm3) 1.23 ± 0.40 1.23 ± 0.40 0.99 1.24 ± 0.40 1.24 ± 0.40 0.99 1.23 ± 0.40 1.24 ± 0.40 0.99
V arm (dm3) 1.24 ± 0.36 1.24 ± 0.36 0.99 1.24 ± 0.36 1.24 ± 0.36 0.99 1.24 ± 0.36 1.24 ± 0.36 0.99
V tot (dm3) 2.47 ± 0.73 2.47 ± 0.73 0.99 2.48 ± 0.73 2.48 ± 0.73 0.99 2.47 ± 0.73 2.48 ± 0.73 0.99
Table I. Intra- and inter-operator analysis of laser scanning 3D at the baseline (T0) and after 2-week treatment (T1).
Data are expressed as means ± standard deviations. Statistical analysis performed was Pearson correlation coefficient.
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 T0 (n=43)
 Intra-operator analysis Inter-operator analysis
 Operator A Operator B Operator A Operator B
 1st measure 2nd measure r2 1st measure 2nd measure r2 Mean Mean r2
  
V1 (dm3) 0.14 ± 0.05 0.14 ± 0.05 0.99 0.14 ± 0.05 0.14 ± 0.05 0.99 0.14 ± 0.05 0.14 ± 0.05 0.98
V2 (dm3) 0.22 ± 0.09 0.22 ± 0.09 0.99 0.22 ± 0.09 0.22 ± 0.09 0.99 0.22 ± 0.09 0.22 ± 0.09 0.99
V3 (dm3) 0.28 ± 0.10  0.28 ± 0.10 0.99 0.28 ± 0.10 0.28 ± 0.10 0.99 0.28 ± 0.10 0.28 ± 0.10 0.99
V4 (dm3) 0.34 ± 0.10 0.34 ± 0.10 0.99 0.34 ± 0.10 0.34 ± 0.10 0.99 0.34 ± 0.10 0.34 ± 0.10 0.99
V5 (dm3) 0.36 ± 0.12 0.36 ± 0.12 0.99 0.36 ± 0.12 0.36 ± 0.12 0.99 0.36 ± 0.12 0.36 ± 0.12 0.99
V6 (dm3) 0.37 ± 0.11 0.37 ± 0.11 0.99 0.37 ± 0.11 0.37 ± 0.11 0.99 0.37 ± 0.11 0.37 ± 0.11 0.99
V7 (dm3) 0.44 ± 0.12 0.44 ± 0.12 0.99 0.44 ± 0.12 0.44 ± 0.12 0.99 0.44 ± 0.12 0.44 ± 0.12 0.99
V8 (dm3) 0.48 ± 0.15 0.48 ± 0.15 0.99 0.48 ± 0.16 0.48 ± 0.16 0.99 0.48 ± 0.16 0.48 ± 0.16 0.99
V forearm (dm3) 1.30 ± 0.41 1.30 ± 0.41 0.99 1.31 ± 0.41 1.31 ± 0.41 0.99 1.31 ± 0.41 1.31 ± 0.41 0.99
V arm (dm3) 1.29 ± 0.38 1.29 ± 0.38 0.99 1.30 ± 0.38 1.30 ± 0.38 0.99 1.30 ± 0.38 1.30 ± 0.38 0.99
V tot (dm3) 2.60 ± 0.77 2.60 ± 0.77 0.99 2.61 ± 0.76 2.61 ± 0.76 0.99 2.61 ± 0.76 2.61 ± 0.76 0.99
 T1 (n=43)
 Intra-operator analysis Inter-operator analysis
 Operator A Operator B Operator A Operator B
 1st measure 2nd measure r2 1st measure 2nd measure r2 Mean Mean r2
  
V1 (dm3) 0.14 ± 0.05 0.14 ± 0.05 0.99 0.14 ± 0.05 0.14 ± 0.05 0.99 0.14 ± 0.05 0.14 ± 0.05 0.99
V2 (dm3) 0.20 ± 0.09 0.20 ± 0.09 0.99 0.20 ± 0.09 0.20 ± 0.09 0.99 0.20 ± 0.09 0.20 ± 0.09 0.99
V3 (dm3) 0.27 ± 0.10 0.27 ± 0.09 0.99 0.26 ±0.10 0.27 ±0.10 0.99 0.26 ± 0.11 0.27 ±0.10 0.99
V4 (dm3) 0.34 ± 0.11 0.34 ± 0.11 0.99 0.34 ± 0.10 0.34 ± 0.11 0.99 0.34 ± 0.11 0.34 ± 0.11 0.99
V5 (dm3) 0.35 ± 0.10 0.35 ± 0.10 0.99 0.35 ± 0.10 0.35 ± 0.10 0.99 0.35 ± 0.10 0.35 ± 0.10 0.99
V6 (dm3) 0.37 ± 0.11 0.37 ± 0.11 0.99 0.37 ± 0.11 0.37 ± 0.11 0.99 0.37 ± 0.11 0.37 ± 0.11 0.99
V7 (dm3) 0.43 ± 0.13 0.44 ± 0.13 0.99 0.43 ± 0.12 0.43 ± 0.13 0.99 0.43 ± 0.13 0.43 ± 0.12 0.99
V8 (dm3) 0.46 ± 0.15 0.46 ± 0.15 0.99 0.46 ±0.13 0.46 ±0.13 0.99 0.46 ± 0.15 0.46 ±0.13 0.99
V forearm (dm3) 1.30 ± 0.45 1.30 ± 0.44 0.99 1.30 ± 0.45 1.30 ± 0.45 0.99 1.30 ± 0.45 1.30 ± 0.45 0.99
V arm (dm3) 1.26 ± 0.39 1.26 ± 0.38 0.99 1.27 ± 0.37 1.26 ± 0.37 0.99 1.26 ± 0.39 1.27 ± 0.37 0.99
V tot (dm3) 2.56 ± 0.80 2.57 ± 0.80 0.99 2.56 ± 0.79 2.56 ± 0.79 0.99 2.56 ± 0.80 2.56 ± 0.79 0.99
Table II. Intra- and inter-operator analysis of circumferential method at the baseline (T0) and after 2-week treatment (T1).
Data are expressed as means ± standard deviations.  Statistical analysis performed was Pearson correlation coefficient.
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The strong correlation between 3DLS and CM 
has been also confirmed by the Bland-Altman 
plot (Figure 3b); this plot has been widely used 
to compare two measurement techniques fo-
cusing on the same parameter, based on the 
assumption that a strong correlation could not 
be synonymous of a strong agreement. Further-
more, we found significant (p<0.0001) correla-
tions in the inter-operator analysis in terms of 
total limb volumes differences after the 2-week 
CDT (T1-T0) for both techniques. It was inter-
esting to notice that 3DLS correlation was high-
er than CM (r2 = 0.85 vs. r2 = 0.64) (Figure 3c 
for further details). 
Figure 3. A, Correlation between three-dimensional laser scanning (3DLS) and circumferential method (CM) at both time-
points; B, Bland-Altman plot showing the level of agreement and the consistency of the two measurements at both timepoints; 
C, Correlation between the inter-rater operator analysis in terms of total limb volume differences after rehabilitative treatment 
of both CM and 3DLS techniques.
A
C
B
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Discussion
BCRL, despite being not lethal per se, is 
strongly detrimental for the HRQoL of BC sur-
vivors with a negative impact on sanitary costs, 
making necessary an early management2,7,8,10-12. 
Thus, it is mandatory to use an accurate and reli-
able tool for limb volume measurement, for both 
an adequate diagnosis and to monitor modifica-
tions induced by rehabilitation in these patients. 
3DLS has already been proved to be a useful tool 
for measuring the upper limb volume18-20 In the 
present study, we demonstrated for the first time 
its reproducibility and reliability also in assessing 
the differences after a specific CDT treatment in 
a cohort of BCRL women.
Several studies addressed arm volume mea-
surement in lymphedema patients and different 
techniques have been investigated and com-
pared13-15,17,18,22-26. Up to date, WD is actually con-
sidered the gold standard in arm volume measure-
ment for both clinical and research purposes13-15. 
However, its main limitation is the inability to 
highlight and measure swelling and gibbousness 
of the arm, crucial for both patients and physi-
cians in high stage lymphedema. Indeed, WD is 
not routinely used in the clinical setting for both 
practical and technical limitations like the pres-
ence of skin lesion, extremely common in these 
patients. The most widely used method in clini-
cal practice is still the CM, although it might be 
subject to errors due to the use of an approximat-
ed formula for the volume calculation (frustum 
formula). These errors could be mainly related to 
the high intra-operator variability, operator expe-
rience and, in case of high stage lymphedema, to 
irregular limb shape (i.e., gibbousness). 
3DLS has been showed to be a promising 
technique for quick volume measurement and it 
has been already compared to WD19 and CM18,20 
for upper limb volume measurement in healthy 
subjects. Firstly, McKinnon et al19 performed a 
pilot study comparing 3DLS to WD in terms of 
a series of regularly shaped objects of known 
volume, a set of irregularly shaped objects of 
unknown volume, and the volume of the arms 
of 10 human volunteers. They showed a mean 
difference between WD volume and 3DLS vol-
ume of 151.7±189.5 ml, and the coefficient of re-
producibility of WD was 450.8 ml, whereas for 
3DLS it was 174 ml. Similar results were recent-
ly obtained by Preu et al33 comparing a 3DLS de-
vice to WD for upper limb volume measurement 
in BCRL patients. They showed no significant 
difference in upper limb volume quantification 
between the two methods in BCRL patients 
(p = 0.807); moreover, 3DLS had a high in-
tra-rater reliability (Intraclass Correlation Coef-
ficient = 0.999) compared to WD, with intriguing 
implications for its clinical implementation in 
routine BCRL diagnosis and rehabilitative treat-
ment. However, the authors underlined the high 
costs of the 3DLS device, the effort in arm refer-
ence points detection and acquisition combined 
with time-consuming software elaboration. 
Recently, Cau et al18 have compared 3DLS to 
CM in 12 healthy subjects, showing a high intra- 
and inter-operator reliability and a satisfactory 
level of agreement for both techniques; however, 
the 3DLS device appeared to be a more accurate 
volume instrument, taking into account the sig-
nificant difference of volumes. Thus, in 2020, in 
a pilot study performed by our group20, we com-
pared the use of a portable 3DLS device to CM 
on 30 healthy subjects and 30 BCRL patients; 
we showed that 3DLS not only had a higher cor-
relation but also was significantly quicker (total 
time including acquisition and digital processing: 
202±27 sec vs. 293±17 sec; p<0.0001) in evaluat-
ing the upper limb volume in both groups. 
Taking into account the previous works in lit-
erature, in the present proof-of-principle study, we 
demonstrated for the first time the reproducibility 
and reliability of a portable 3DLS device com-
pared to CM in measuring upper limb volumes 
in a cohort of BCRL women before and after the 
rehabilitation treatment, assessing the improve-
ment obtained through the CDT. These findings 
are intriguing considering the relative quickness, 
accuracy, and reproducibility of the 3DLS; more-
over, these data suggest a relatively fast learning 
curve of this device, at least comparable to CM. 
Taken together, all these points might sug-
gest crucial implications for the implementation 
of portable 3DLS techniques in different real 
practice clinical settings (i.e., outpatient or home 
care) and for the potential reduction of health 
sanitary costs in terms of both personnel and 
procedures costs. 
However, this study has several limitations: 
firstly, the small sample size, although compara-
ble and slightly higher than similar studies pub-
lished in the literature about this topic; secondly, 
3DLS was not compared to WD, considered as 
the gold standard for limb volume measurement, 
because we have chosen the CM, the most widely 
used technique in order to obtain data with direct 
implications in clinical practice. 
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In this proof-of-principle study, we confirmed 
that the 3DLS technique is a highly sensitive, re-
producible, and easy-to-use method in evaluating 
the upper limb volume in BCRL women. More-
over, to the best of our knowledge, this is the first 
study that demonstrated the reproducibility and 
reliability of a 3DLS device also in detecting vol-
umetric differences in the upper limb after a spe-
cific rehabilitation treatment in a cohort of BCRL 
patients. Therefore, this method might have posi-
tive implications for lymphedema management in 
the clinical practice, considering the key role of 
augmented reality technologies in BCRL clinical 
workup. 
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